Adma Biologics: Falls On Wider: than-expected Q1 loss

ADMA Biologics

07/05/2020 18:22

** Shares of drug developer  ADMA.O  fall 16.9% to $2.66 
    ** ADMA reported Q1 loss of 26 cents per share compared with
Wall Street estimates of a loss of 12 cents/share - Refinitiv
data  urn:newsml:reuters.com:*:nASA00O6Z
    ** Co's Q1 rev of $10.2 mln also missed analyst expectations
of $10.9 mln
    ** Oppenheimer halved ADMA's PT to $7
    ** Over 4.2 mln shares traded, 2x their 25-day moving
average
    ** All 7 brokerages that cover stock have rated it "buy" or
higher; their median PT is $10
    ** Including session's loss, ADMA stock has fallen ~33% YTD,
underperforming the 6.3% YTD gain in broader Nasdaq
Biotechnology Index  .NBI 

 (Reporting by Shivani Singh in Bengaluru)
 ((ShivaniSingh1@thomsonreuters.com; +91 80 6182 2803 (direct),
+1-646-223-8780 (extension 2803);))